Human herpesvirus entry mediator C (HveC) is an alphaherpesvirus receptor which binds to virion glycoprotein D (gD). We identified porcine HveC and studied its interaction with pseudorabies virus (PrV) and herpes simplex virus type 1 (HSV-1) gD. Porcine and human HveC have 96% amino acid identity and HveC from African green monkey, mouse, hamster, and cow are similarly conserved. Porcine HveC mediates entry of HSV-1, HSV-2, PrV, and bovine herpesvirus type 1. Truncated soluble forms of HSV-1 and PrV gD bind competitively to porcine HveC. Biosensor analysis shows that PrV gD binds with a 10-fold higher affinity than HSV-1 gD. Monoclonal antibodies against human HveC recognize the porcine homologue and can block gD binding and entry of HSV-1 and PrV. Porcine HveC is functionally indistinguishable from human HveC. Our results are consistent with the suggestion that HveC is a pan-alphaherpesvirus receptor that interacts with a conserved structural domain of gD.
INTRODUCTION
An early step in the entry of most alphaherpesviruses into cells is the interaction of the virion envelope glycoprotein D (gD) with one of numerous cell surface receptors . To date, five human alphaherpesvirus receptors have been identified: herpes virus entry mediator A (HveA, also known as HVEM and TNFRSF14), a TNF receptor-related protein (Montgomery et al., 1996) ; three immunoglobulin superfamily members: HveB (PRR2, nectin 2), HveC (PRR1, nectin 1) and HveD (PVR, CD155); and 3-O-sulfated heparan sulfate (Cocchi et al., 1998b; Geraghty et al., 1998; Shukla et al., 1999a; Warner et al., 1998) . Although by definition each of these receptors mediates entry of at least one alphaherpesvirus, only one, HveC, can serve as a receptor for all of the commonly tested viruses: herpes simplex virus type 1 (HSV-1), HSV-1 rid mutants, HSV-2, pseudorabies virus (PrV), and bovine herpesvirus type 1 (BHV-1; Cocchi et al., 1998b; Geraghty et al., 1998) .
The 346-amino acid extracellular domain of HveC comprises 3 immunoglobulin (Ig)-like domains (Lopez et al., 1995) . The most N-terminal resembles a variable (V) domain and the other two resemble constant (C) domains. This overall structure is shared with HveB and with the most recently described member of this group of proteins, nectin 3 (Satoh-Horikawa et al., 2000; R.S.B. Milne et al., unpublished) . The natural function of HveC is in cell adhesion. The C-terminus of HveC interacts with an intracellular actin-binding protein, afadin, which in turn localizes to cadherin adhesion junctions (Takahashi et al., 1999) . HveC is thought to participate in adhesion via a homophilic trans interaction in which HveC on the surface of one cell binds HveC on the surface of an adjacent cell (Takahashi et al., 1999) .
The entry mechanism of HSV and other alphaherpesviruses remains poorly understood. The initial contact between HSV and a host cell is thought to be the interaction of viral glycoproteins C and B with cell surface proteoglycans (Herold et al., 1994; WuDunn and Spear, 1989) . Subsequently, the fusion of viral envelope and cell membrane is brought about by the concerted actions of at least four viral glycoproteins: gB, gD, gH, and gL (Spear, 1993) . Of the HSV-1 glycoproteins, only these four are indispensable for normal virus entry in vitro (Cai et al., 1988; Forrester et al., 1992; Ligas and Johnson, 1988; Roop et al., 1993) and expression of the four proteins can cause cell fusion (Klupp et al., 2000; Muggeridge, 2000; Turner et al., 1998) . To date, only gD has a clearly demonstrable function: receptor binding Krummenacher et al., 1998; Whitbeck et al., 1997) .
gD is present in all of the commonly studied alphaherpesviruses, except for varicella-zoster virus, and is the viral ligand for all of the recently identified alphaherpes-virus receptors. The gD homologues are considerably diverged with, in the case of HSV-1 and PrV, only about 30% amino acid identity. However, the 6 cysteine residues in the extracellular domain are conserved, implying that a common structure is retained. The remarkable ability of all the gD homologues that have been tested to bind HveC underlines the fact that the alphaherpesviruses have a common entry mechanism and highlights the central role of the gD-HveC interaction in this.
Given that human HveC can mediate entry of the animal alphaherpesviruses PrV and BHV-1 (Cocchi et al., 1998b; Geraghty et al., 1998) , it follows that HveC homologues in other mammalian species may serve as receptors for native alphaherpesviruses (Cocchi et al., 1998b; Warner et al., 1998) . The murine homologue of HveC has been cloned and shown to be a functional alphaherpesvirus receptor (Menotti et al., 2000; Shukla et al., 2000) . However, despite the use of PrV and BHV-1 in the characterization of alphaherpesvirus receptors, information about receptors from their natural host species is lacking. We set out to test the hypothesis that alphaherpesviruses use HveC from their native hosts by studying the interaction of PrV with porcine HveC.
PrV is the most intensively studied animal alphaherpesvirus and its gD homologue has been well characterized (Rauh and Mettenleiter, 1991) . There are significant functional differences between HSV-1 and PrV gD. PrV cannot use HveA for entry, but can use HveB and HveD, whereas for wild-type HSV-1 the reverse is true (Cocchi et al., 1998b; Geraghty et al., 1998; Montgomery et al., 1996; Warner et al., 1998) . We recently showed that a truncated soluble form of PrV gD binds human HveC with high affinity . We were therefore interested to test whether PrV gD binds similarly to porcine HveC or whether the established structural and functional differences between PrV and HSV-1gD were reflected in different interactions with the HveC homologues from their natural host species.
In this article we show that the HveC homologues from various mammalian species are remarkably conserved, that PrV and HSV-1 gDt bind to porcine HveC competitively but with different affinities, and that, with regard to herpesvirus entry, porcine HveC is functionally indistinguishable from its human homologue.
RESULTS

HveC is highly conserved among mammalian species
Human HveC mediates entry of HSV-1, HSV-2, PrV, and BHV-1 (Cocchi et al., 1998b; Geraghty et al., 1998) ; however, of these, only HSV-1 and -2 naturally infect humans. The ability of viruses from other species to use human HveC implies that animal homologues of this receptor might play a role in the entry of native alphaherpesviruses. It has not been clear whether studies of the interactions of animal viruses, such as PrV, with human receptors adequately model their interactions with receptors from their natural hosts. To address this issue and to provide a more biologically relevant analysis of PrV gD function, we decided to study porcine HveC. Initially, we asked whether there were HveC homologues in other mammalian species.
Using RT-PCR we amplified and then sequenced a region of cDNA encoding the extracellular domain of HveC from position 42, just downstream of the start of the V domain, to position 336, the point at which the two known splice isoforms diverge (Cocchi et al., 1998b; Geraghty et al., 1998; Lopez et al., 1995) . HveC sequences were amplified from RNA extracted from Vero (African green monkey), BHK (hamster), MDBK (bovine), and PK15 (porcine) cells. A single PCR product band was obtained from all cell types without the need for nested reactions, suggesting that, at least in these cell types, HveC transcripts are relatively abundant.
The nucleotide sequences (including those published for human and murine HveC) showed greater than 88% identity for all pairwise comparisons. The deduced amino acid sequences showed a remarkable degree of conservation (Fig. 1 , Table 1 ) with greater than 90% identity for all pairwise comparisons. The closest pairs were human and monkey as well as mouse and hamster, each with 98% identity.
Interestingly, the HveC sequence from Vero cells contained a 3-amino acid insertion (Ile Thr Gln) after residue Lys-69 of the V domain (Fig. 1) . This falls within an extended region between the predicted C and CЈ beta strands according to a published HveC structural model (Krummenacher et al., 2000; Wimmer et al., 1994) . The insertion was not an artifact of the lengthy passage history of Vero cells, as the HveC extracellular domain sequence amplified from another African green monkeyderived cell line, COS7, was identical (data not shown). The insertion appears to have arisen from a duplication event, as the nucleotide sequence is a direct repeat of one a short distance upstream (encoding residues 62-64).
Having confirmed that a HveC homologue was expressed in porcine cells we determined its complete nucleotide sequence. We used RACE to obtain the 5Ј and 3Ј ends of the porcine HveC sequence from PK15 RNA. Both the splice isoforms of HveC (Cocchi et al., 1998b; Geraghty et al., 1998; Lopez et al., 1995) were detected (data not shown). We then PCR-amplified and cloned the complete porcine HveC open reading frame.
The porcine HveC nucleotide sequence was 92% identical to that of human HveC and 90% identical to murine HveC (Menotti et al., 2000; Shukla et al., 2000) . The 515-amino acid sequence of porcine HveC was 96% identical to the published human HveC sequence with 18 amino acid substitutions and two deleted residues (Glu 443 and Gly 444 in the human HveC sequence). The deletions occur within the cyto-plasmic domain of HveC at the end of a run of seven Glu residues. Both murine and rat HveC (Takahashi et al., 1999) also have Glu 443 deleted. The porcine HveC amino acid sequence is 93% identical to murine (C3H allele) HveC, with 32 substitutions, one insertion (Pro 343 in the porcine sequence), and one deletion (Gly 447 in the murine sequence).
Porcine HveC is a functional alphaherpesvirus receptor
We next asked whether porcine HveC was able serve as a receptor for a panel of four alphaherpesviruses. To answer this question, we transfected CHOK1 cells with plasmid pRM361 encoding porcine HveC, or as controls, pBG38 encoding human HveC, or the vector pcDNA3, and then exposed them to lacZ reporter viruses. CHOK1 cells do not express any of the known alphaherpesvirus receptors and are therefore resistant to HSV-1 entry (Shieh et al., 1992) and relatively resistant to PrV entry (Nixdorf et al., 1999) . Transient expression of porcine HveC made CHOK1 cells susceptible to entry of HSV-1, HSV-2, PrV, and BHV-1 (shown for HSV-1 and PrV in Fig. 2 ). As expected, the human HveCtransfected cells gave the same results, suggesting that the two forms of HveC are functionally equivalent. The apparent clusters of infected cells (Fig. 2, panels 1, 2, 3 , and 4) may be due to cell division after transfection, or may stem from the gD-independent spread that can occur to some degree with both viruses (Brunetti et al., 1995; Peeters et al., 1992a) .
To confirm these findings and to provide a more standardized method for studying porcine HveC-mediated entry we generated a CHO K1-derived cell clone, referred to as CHOpHveC, that stably expressed porcine HveC. Titration of HSV-1, HSV-2, PrV, and BHV-1 lacZ reporter viruses on (Thompson et al., 1994) was used for the multiple alignment followed by manual adjustment. Only alterations from the human sequence are shown. The V domain is underlined, the first C domain is wavy underlined, and the second C domain is dash underlined. The putative gD-binding region of the V domain (Krummenacher et al., 2000) is double underlined. The alignment starts at position 42 of the complete human HveC sequence. The human (GenBank Accession No. AF060231) and mouse (GenBank Accession No. AF239762) sequences are as published Menotti et al., 2000) . CHOpHveC cells gave dose-dependent ␤-galactosidase signals, whereas titrations on control cultures of parental CHO K1 cells gave minimal background signals (data not shown). Quantitative comparisons of the efficiency of entry of different viruses were not possible in this system because of the different promoters used to drive lacZ expression. However, it was clear that porcine HveC mediates entry of the same range of alphaherpesviruses as its human and murine homologues.
HveC-specific MAbs block porcine HveC-mediated entry
The high sequence identity of human and porcine HveC made it likely that human HveC-specific MAbs would recognize both forms of the protein. We used CELISA to test cell surface expression of porcine HveC on CHOpHveC cells and PK15 cells. Conformation-dependent (CK41) and linear (CK6 and CK8) MAbs raised against human HveC (Krummenacher et al., 2000) recognized porcine HveC expressed on the surface of CHOpHveC and, to a lesser extent, on the surface of PK15 cells (Fig. 3) . On the recombinant cells, where sufficient HveC is expressed for MAb binding to approach saturation, the amount of CK6 and CK8 bound appeared to be twice the amount of CK41. HveC is thought to be oligomeric and it is possible that only one CK41 epitope is accessible in the native form of the molecule.
Human HveC-mediated entry of HSV-1 (Cocchi et al., 1998b; Krummenacher et al., 2000) and PrV (data not shown) can be blocked by preexposure of cells to certain HveC V domain-specific MAbs. We showed recently that truncated soluble forms of PrV and HSV-1 gD (termed gDt) bind to an overlapping region of the V domain of human HveC ). Having shown above that HveC V domain-specific MAbs recognized porcine HveC on the cell surface, it was of interest to determine whether they could block porcine HveC-mediated entry of HSV-1 and PrV. Titration of the conformation-dependent HveC V domain-specific MAbs CK41 and R1.302 (Lopez et al., 1997) on CHOpHveC prior to exposure to HSV-1 or PrV caused a dose-dependent inhibition of entry (Fig. 4) . We next asked whether HveC-specific MAbs could block entry of PrV to PK15 cells. Surprisingly, while HSV-1 entry was inhibited, PrV entry was unaffected (shown for MAb R1.302 in Fig. 4C ).
We conclude from these experiments that porcine HveC retains a high level of structural and antigenic similarity with human HveC which is reflected in the cross reactivity of linear and conformation-dependent MAbs. Additionally, it seems that PrV and HSV-1 use a similar site on porcine HveC to enter CHOpHveC cells. The failure of HveC MAbs to block entry of PrV to PK15 cells, which express functional HveC on the surface, suggests that this virus may use another receptor for entry to these cells.
Porcine HveCt binds PrV and HSV-1 gD
Having shown that porcine HveC was a functional receptor for PrV as well as for other alphaherpesviruses, we next wanted to examine its interaction with gD. We have previously used the baculovirus system to express
Porcine HveC-mediated entry of alphaherpesviruses. CHO K1 cells were transfected with pRM361, encoding porcine HveC (panels 1 and 2); pBG38, encoding human HveC (3 and 4) or the control vector pCDNA3 (5 and 6); 48 h after transfection, cells were infected with PrV BeBlu (panels 1, 3, and 5) or HSV-1 hrR3 (panels 2, 4, and 6). Infected cells were visualized by X-gal staining. truncated soluble forms of human HveC and therefore used the same system to express porcine HveC. Soluble porcine HveC, truncated at position 346 just upstream of the transmembrane domain (termed porcine HveCt), was purified to homogeneity using nickel agarose. The structural integrity of the purified protein was confirmed by recognition, in ELISA, by MAbs against linear epitopes in all three Ig domains (not shown) and by two different conformational MAbs against the V domain (Fig. 5) .
One linear V domain MAb, CK17, bound less well to porcine HveCt than to human HveCt, with about 50-fold more MAb needed to generate an equivalent signal in ELISA to that obtained with human HveC (Fig. 5) . The CK17 epitope is contained within a peptide corresponding to positions 80 to 94 of the human HveC sequence (Krummenacher et al., 2000) . Porcine HveC contains an alanine in place of serine at position 84 (Fig. 1) . This , or PK15 cells (C) were stained with HveCspecific MAbs CK6 (s), CK8 (F), CK41 (OE), or as control the HveAspecific MAb CW3 (}). Bound MAb was detected using peroxidaseconjugated secondary antibody and absorbance was measured at 405 nm. Each point is the mean of duplicate wells. change could impede CK17 binding thereby implying that the CK17 epitope includes the N-terminal portion of this peptide. Thus porcine HveCt is antigenically similar to its human homologue.
We and others have previously demonstrated direct binding of HSV-1 (Cocchi et al., 1998a; and PrV gDt to the V domain of human HveC. So, having shown that porcine HveC was a bona fide receptor, we next used ELISA to test whether HSV-1 gDt and PrV gDt were able to bind porcine HveCt. Both forms of gDt bound to porcine HveCt in a dose-dependent manner (Fig. 6) . The binding curves for each form of gDt obtained with human HveCt and porcine HveCt could be superimposed, suggesting that the two truncated receptors were functionally similar and that, at least with regard to gD binding, porcine HveCt retained a conformation similar to that of human HveCt.
HveC-specific MAbs block binding of PrV and HSV-1 gD to porcine HveCt
We showed above that certain HveC-specific MAbs were able to block porcine HveC-mediated entry of HSV-1 and PrV. It was likely that this was due to a direct effect of the MAbs on gD binding. We therefore used ELISA to test these MAbs for the ability to block binding of gDt to HveCt.
Titration of HveC-specific MAbs CK41 and R1.302 caused a dose-dependent decrease in the binding of PrV and HSV-1 gD to human and porcine HveCt (Fig. 7) . R1.302 was consistently more effective at blocking than CK41 and appeared to have an identical effect regardless of receptor or gD. CK41 blocked HSV-1 gD somewhat more effectively than PrV gD. Thus, MAbs CK41 and R1.302 have similar but distinct properties. Both block binding of gDt to immobilized porcine HveCt and this is probably the mechanism by which they inhibit virus entry.
Porcine HveC binds HSV-1 and PrV gD with different affinities
Our previous studies of the interaction of human HveC with HSV-1 and PrV gDt showed that the affinity of the interaction is approximately 10-fold higher with PrV gD than with HSV-1 gD . It was possi- ble that the higher affinity of PrV gD for human HveCt might reflect an abnormal interaction with a receptor from a species that is not a normal host for PrV. If so, the affinity for porcine HveC might be expected to be equivalent to that of HSV-1 gD for human HveC. Alternatively, if the higher affinity were a genuine feature of the PrV gD-HveC interaction it would, presumably, be the same for porcine HveC.
To distinguish between these two possibilities, we used competition ELISA to compare binding of the two forms of gDt and to test whether they could compete for binding to porcine HveCt. We showed previously that PrV and HSV-1 gDt compete for binding to human HveCt . In the next experiments, porcine HveCt was immobilized on the ELISA plate and increasing concentrations of one form of gDt were used to compete the binding of a constant concentration of the other form of gDt.
PrV gDt effectively competed binding of HSV-1 gDt to porcine HveCt, with 50% inhibition of HSV-1 gDt binding at a concentration of approximately 0.2 M (Fig. 8) . By contrast, HSV-1 gDt competed PrV gDt binding much less effectively, with only about 60% inhibition of PrV gDt binding at the highest concentration of HSV-1 gDt tested (10 M). The disparity between the ability of the two forms of gDt to compete binding was consistent with the higher affinity of PrV gDt for human HveC and suggested that this was also true for porcine HveC. Furthermore, the competition curves shown in Fig. 8 could be superimposed on similar curves generated with human HveCt (data not shown); thus it appeared that the species origin of the receptor did not affect gD binding.
To confirm and quantitate the affinity difference between HSV-1 and PrV gDt we used optical biosensor analysis. We have previously used this technique to study the interaction of various forms of gDt with receptors Rux et al., 1998; Whitbeck et al., 1999; Willis et al., 1998b) . We therefore used this approach to compare the interaction of PrV and HSV-1 gDt with the porcine HveCt.
Different concentrations of PrV gDt or HSV-1 gDt were flowed over porcine HveCt immobilized on a biosensor chip and binding and dissociation were monitored in real time (Fig. 9) . Binding data were analyzed using a 1:1 interaction model to generate estimates of the association and dissociation rates and the affinity (Table 2) . PrV gDt bound with an affinity (K D ) of 1.9 ϫ 10 Ϫ7 M, whereas the affinity of HSV-1 gDT was significantly lower at 1.9 ϫ 10 Ϫ6 M. This result was consistent with the ELISA results described above. The 10-fold higher affinity of PrV gDt stemmed almost entirely from a higher on-rate (k on ); that is, PrV gDt bound to immobilized HveCt more rapidly than did HSV-1 gDt (on-rate of 7.6 ϫ 10 4 s Ϫ1 M Ϫ1 for PrV gDt compared to 4.4 ϫ 10 3 s Ϫ1 M Ϫ1 for HSV-1 gDt). Comparison of the binding kinetics of the two forms of gD for porcine HveC with the published data for their interaction with human HveC Connolly et al., 2001) shows that, for both forms of gDt, the affinities for human and porcine HveC are essentially identical.
DISCUSSION
Alphaherpesviruses are a diverse group with representatives that infect a huge variety of mammalian species. There is ample evidence that HSV-1 and PrV, the most widely studied members of the group, and probably all of the mammalian alphaherpesviruses, share a common entry pathway. At the most general level, they encode the same set of entry glycoproteins (Mettenleiter, 1994; Spear, 1993) Peeters et al., 1992b; Rauh and Mettenleiter, 1991; Roop et al., 1993) . Additionally, PrV and HSV-1 can compete for binding to Vero cells and expression of gD from either virus can block infection with both viruses (CampadelliFiume et al., 1988; Geraghty et al., 2000; Johnson and Spear, 1989; Lee and Fuller, 1993) . The latter observations can be explained by the demonstrated ability of PrV and HSV-1 to use a common receptor, HveC.
The rationale for the work described in this article was that if PrV can use human HveC as a receptor then it was 
FIG. 9. Real time analysis of PrV and HSV-1gDt binding to porcine HveCt. The indicated concentrations of PrV gDt (A) or HSV-1gDt (B)
were flowed for 2 min (association) across porcine HveCt immobilized on a CM5 BIACORE chip in a BIAcore X instrument. Buffer alone was then flowed for 2 min to allow dissociation. Data were collected at 5 Hz. The sensorgrams represent raw data with signals from a blank control flow cell and from injections of buffer alone subtracted. For clarity one of every 25 collected data points is plotted. The solid lines represent the best fit of the complete data set using global fitting. likely to be able to use a porcine HveC homologue. Because of the considerable sequence differences between HSV and PrV gD, studies of their interactions with HveC homologues from their natural hosts would be of use in dissecting gD function. We initially set out to determine whether pigs and other mammalian species encoded HveC homologues. The conservation of HveC amino acid sequences was striking, with greater than 90% identity over the extracellular domain in all pairwise comparisons. The related proteins HveB and nectin 3 are also highly conserved between species with 72% (HveB) and 92% (nectin 3) amino acid identities between the human and the murine homologues (Satoh-Horikawa et al., 2000; Shukla et al., 1999b; Warner et al., 1998) . One explanation for the high sequence conservation of this distinct group of immunoglobulin superfamily proteins is the homophilic interaction that they can undergo (Lopez et al., 1998; SatohHorikawa et al., 2000; Takahashi et al., 1999) . Given that each is effectively its own ligand, a single mutation can be thought of as simultaneously altering both receptor and ligand with a correspondingly enhanced effect, perhaps creating a strong pressure for conservation. Although HveC is remarkably conserved, alignment of all of the known HveC extracellular domain sequences shows that a total of 30 residues are varied in at least one sequence. Variant residues appeared to be distributed evenly over the protein with 13 in the V domain (which is larger than the two C domains), 5 in the first C domain and 4 in the second C domain, and 8 in spacer regions between domains.
As well as point mutations, we found a 3-amino acid insertion in the HveC V domain sequence from Vero cells. Entry of HSV-1 and PrV into Vero cells can be partially blocked by HveC MAbs (data not shown), indicating that Vero HveC is able to mediate virus entry. It should be noted that the insertion in Vero HveC is outside of the predicted gD-binding region of HveC ( Fig. 1 ; Krummenacher et al., 2000) . The observation that entry of both viruses into Vero cells can be blocked by HveC MAbs provides a likely explanation for the published observation that PrV and HSV-1 can compete for a receptor on Vero cells (Lee and Fuller, 1993) . Our data would suggest that this receptor was HveC, which is consistent with this being the only known receptor that is used by both viruses .
Having shown that porcine HveC was highly similar to human HveC, we then wanted to study its ability to function as a virus receptor. Despite their high sequence identity, it was possible that porcine and human HveC might differ in their receptor activity. In fact, we found that porcine and human HveC were functionally indistinguishable.
We showed previously that the binding affinity of PrV gDt for human HveCt was 10-fold higher than that of HSV-1gDt (Connolly et al., 2001) . Here, we found that the same was true with porcine HveCt. It is curious that although PrV and HSV-1gDt both bind HveCt, possibly at the same site, they do so with differing affinities. This may reflect a fundamental difference between the two viruses in the ways in which HveC functions as a receptor. However, given the similar entry pathways of the two viruses, this seems unlikely. An alternative explanation is that the higher affinity is due to structural differences, for example, the lack of N-glycosylation on PrV gDt. High affinity binding may contribute to the ability of PrV to use a broad range of receptors Warner et al., 1998) . In this regard, it would be interesting to determine the affinities of PrV gDt for its other receptors, HveB and HveD.
We could not block PrV entry to PK15 cells with HveC MAbs. By contrast, HSV-1 entry could be partially blocked, confirming our CELISA data that HveC on PK15 cells is accessible and showing that, at least for HSV, it is functional. The higher affinity of PrV gD for HveC is unlikely to be the explanation for the failure of blocking, as we showed that HveC-mediated entry of PrV to CHOpHveC cells can be blocked by these MAbs. In a study of PrV entry to murine cell lines, Shukla et al. found that anti-murine HveB MAbs almost completely blocked PrV entry into B78H1 cells yet had no effect on entry into NIH3T3 cells, although both these cell types express murine HveB mRNA (Shukla et al., 1999b) . It was suggested that PrV was able to use another receptor to enter NIH3T3 cells. For blocking with MAbs to be detectable, the target receptor must account for a substantial proportion of total virus entry. PrV can use three known receptors Shukla et al., 1999b; Warner et al., 1998) and the existence of cells that are resistant to HSV but susceptible to PrV (Cocchi et al., 1998b; Perez and Fuller, 1998) indicates that there is at least one unknown PrV receptor. The lack of blocking on PK15 cells may reflect the preferential use of one or more of the latter. Perhaps for a similar reason, the efficiency with which HSV-1 entry can be blocked varies widely according to cell type (Krummenacher et al., 2000) . We have not investigated the expression of any other receptors on PK15 cells.
It remains the case that, while our data show clearly that PrV can use porcine HveC as a receptor, we have no evidence that this receptor is actually used in vivo. Indeed, such formal proof does not yet exist for any of the recently identified alphaherpesvirus receptors. It seems very unlikely, however, that gD, which shows considerable sequence variation within the alphaherpesviruses, would retain the ability to bind to multiple receptors, particularly to the most widely used, HveC, if these were not used in vivo.
The functional equivalence of human and porcine HveC is not surprising in view of their high sequence identity. HveC mediates entry of a broader range of viruses than any of the other known receptors and HSV-1 and PrV have now been shown to use HveC from four species (human, mouse, pig, and monkey). It may well be that most, if not all, alphaherpesviruses are able to use HveC. Coupled with its striking conservation, this suggests that HveC, unlike the other known alphaherpesvirus receptors, has some of the attributes of a pan-alphaherpesvirus receptor. The widespread use of HveC is remarkable given the extent of sequence divergence between the viral gD homologues. An obvious implication is that the HveC-binding domain of gD has remained highly stable through evolution and/or that it is essential for gD function. It has been suggested that the U S segment of alphaherpesviral genomes, in which gD is encoded, might contain sequences that were acquired from the host (McGeoch, 1989) . Given that HveC interacts with itself, it is tempting to speculate that gD, or at least the HveC-binding domain of gD, might be derived from a segment of the host HveC gene and hence able to mimic this interaction by virtue of a similar structure. Regardless of the origin of gD, the existence of divergent viral ligands able to bind to a highly conserved receptor provides an interesting model system for refining our understanding of receptor structure and function.
MATERIALS AND METHODS
RNA isolation, polymerase chain reaction, and DNA sequencing RNA was extracted from 2 ϫ 10 6 cells using TRIzol (BRL) according to the manufacturers instructions. Contaminating DNA was removed by DNase digestion. Complementary DNA was synthesized from 2 g total RNA using Moloney murine leukemia virus reverse transcriptase (BRL). HveC extracellular domain sequences were amplified by polymerase chain reaction (PCR) using Expand High Fidelity polymerase mix (Boehringer Mannhein) with the upstream primer hPRR1 5Ј, GCGTGATCAGGTGGTCCAGGTGAAC-GACTCCATGTAT, and downstream primer hPRR1 3ЈH-, CGGTGATCAATGTTCGGGAGGAGACGGGGTGTA . Fifty-microliter amplification reactions contained 1.75 units enzyme activity, 0.4 mM each dNTP, 0. 15 M each primer, and 1.5 mM MgCl 2 in the manufacturer's reaction buffer. PCR was carried out on a Perkin-Elmer GeneAmp PCR system 9700 thermal cycler with an initial denaturation at 94°C for 30 s, then 40 cycles of: 94°C, 30 s; 60°C, 30 s; 72°C, 2 min. Product bands (predicted size: 976 base pairs) were purified from agarose using Geneclean spin columns (BIO101) and sequenced at the University of Pennsylvania Department of Genetics DNA sequencing facility using an ABI 377 automated sequencer. PCR products generated from two separate RNA samples were used to assemble each sequence.
Sequences of the 5Ј and 3Ј ends of the porcine HveC sequence were obtained using 5Ј and 3Ј rapid amplification of cDNA ends (RACE), both according to supplied protocols (BRL). For 5Ј RACE, first-strand cDNA synthesis was primed with hPRR13ЈH-. HveC C2ND3, CGGCCCGGGCTAATGAT-GATGATGATGATGCTGCACGTTGAGAGTGAGGCTTTCC, was used as gene specific primer (GSP) and HveC C1ST3, CGGCCCGGGCTAATGATGATGATGATGATGCATCACCGT-GAGATTGAGCTGGCTTTCT, as nested GSP. For 3Ј RACE, hPRR15Ј was used as GSP then primers HveCGSP2, CCAGCTCAATCTCACGGTGATG, and HveCGSP3, CTAT-GTCGACCAGCATCCTGCTGGTGCT, were used as nested GSPs. Products were either cloned or sequenced directly.
The complete porcine HveC nucleotide sequence was amplified using Pfu polymerase (Stratagene). Conditions were as above except that the manufacturer's buffer was used and annealing was at 51°C for 1 min. Primers were pHveC 5. 1, GGACCCGTCGACCCCGATGGCT and pHveC 3.2, CTGAGCGTCGACGCGGTTACACGTACCACTCCT-TCTTGGA, each containing a SalI site (underlined) for cloning. The band-purified product was cloned into XhoIdigested pCDNA3. 1 as a SalI fragment. Clones from three independent PCR amplifications were used to confirm the sequence. One clone, pRM361, was used in all subsequent experiments.
All HveC sequence numbering in this article corresponds to human HveC and starts at the first methionine. The nucleotide sequences described in this article have been deposited in the GenBank data base with the following accession numbers: AF308632 (porcine HveC), AF308635 (Vero HveC extracellular domain), AF308634 (BHK HveC extracellular domain), and AF308633 (MDBK HveC extracellular domain).
Cells and viruses
Vero and PK15 cells were maintained in Dulbecco's minimal essential medium (DMEM) supplemented with 5% fetal calf serum, 100 U/ml penicillin, and 100 g/ml streptomycin. CHO K1 and B78C10 were maintained in Ham's F12 medium supplemented with 10% FCS and antibiotics. This medium was further supplemented with 500 g/ml G418 for maintenance of CHOpHveC and 250 g/ml G418 and 150 g/ml puromycin for B78C10, which are murine B78 H1 cells stably expressing human HveC (C.G. Miller et al., submitted) .
Suspension cultures of Spodoptera frugiperda Sf9 cells were maintained in Sf900II medium (BRL). For monolayer cultures Grace's medium (BRL) supplemented with 10% FCS and antibiotics was used.
␤-galactosidase-expressing reporter viruses were used throughout this project. HSV-1 hrR3 was provided by S. Weller (University of Connecticut) and contains the Escherichia coli lacZ gene at the ICP6 (UL39) locus under the control of the ICP6 promoter (Goldstein and Weller, 1988) . PrV BeBlu was provided by L.Enquist (Princeton University) and contains the lacZ gene at the glycoprotein G locus under the control of the gG promoter (Banfield et al., 1998) . HSV-1 hrR3 was grown and titrated in Vero cells, PrV BeBlu in PK15 cells.
Antibodies and purified proteins
The HveC-specific MAbs CK6, CK7, CK8, CK17, and CK41 were raised against baculovirus-expressed human HveC(346t) and have been described (Krummenacher et al., 2000) . The anti-HveC MAb R1.302 (Lopez et al., 1997) was obtained from S. McClellan (Beckman Coulter). MAb CW3 recognizes HveA and was used as a negative control. IgG were purified from ascitic fluids using protein G Sepharose. Rabbit polyclonal serum R7 was raised against HSV2 gD purified from transfected cells (Isola et al., 1989) . Rabbit polyclonal anti PrV gD serum was obtained from M.W. Wathen. Anti-PrV gD MAb S4B1.1611 was provided by N.Coe (Coe and Mengeling, 1990 ) and MAb 6D8 MB4 was obtained from the ATCC.
Production and purification of baculovirus-expressed HSV-1 gD(306t), termed HSV-1gDt in this article, PrV gDt and human HveC(346t), termed human HveCt in this article, have been described Sisk et al., 1994; Connolly et al., 2001) .
Protein expression and purification
The porcine HveC extracellular domain sequence was amplified by PCR using Pfu polymerase with primers hPRR15Ј and hPRR13Ј, CGGTGATCAATGATGATGATGAT-GATGTTCGGGAGGAGACGGGGTGTA . The product was cloned into pVTBAC producing pRM362 which was used to generate recombinant baculovirus using established methods (Willis et al., 1998a) . The resulting soluble truncated form of porcine HveC, termed Porcine HveCt, contained residues 31 to 345 of the protein with an extra aspartic acid residue at the N-terminus introduced from the vector and a sixhistidine tag introduced by primer hPRR13Ј at the Cterminus. Porcine HveCt was purified on a nickel-agarose column and then concentrated using an Ultrafree centrifugal filter device with a 10K cutoff (Millipore). The purified protein appeared as a single band on silverstained gel and was reactive with HveC MAbs by Western blot and ELISA.
Enzyme-linked immunosorbent assay (ELISA)
For the gD binding ELISA, porcine or human HveCt (10 g/ml in PBS) was coated onto microtiter plates for 2 h at room temperature (RT). Plates were washed with 0.1% Tween 20 in PBS (PBS-Tween), blocked by incubation (1 h RT) with PBS containing 5% powdered milk and 0.2% Tween 20 (blocking solution), washed again, and then incubated overnight with various concentrations of gDt in blocking solution. Bound HSV-1gDt was detected using R7 antiserum (1/1000 in blocking solution) and bound PrV gDt using polyclonal anti-PrV gD serum (1/500 in blocking solution) or a cocktail of MAbs 6D8MB4 and S4B1-1611 (1/500 and 1/750 dilutions of ascitic fluid in blocking solution). Horseradish peroxidase-conjugated goat antimouse Ig or anti-rabbit Ig was used to detect bound antibodies as described . For MAb binding ELISA, plates were coated with receptor at 4°C overnight, washed, blocked as above, and then incubated (2 h RT) with various concentrations of MAb in blocking solution. For blocking ELISA, plates were coated with HveC as in the gD binding ELISA, incubated (2 h RT) with MAbs, washed, and incubated (1 h RT) with gDt (0.5 M) in blocking solution. Bound gDt was detected as above. For competition ELISA, one form of gD (competing gD) was used to block binding of the other form (test gD) to immobilized HveC. Plates were coated with HveC as in the gD binding ELISA and then incubated (4°C overnight) with various concentrations of competing gDt, or BSA as control, and 0.5 M test gDt. Bound test gD was detected as above.
CELISA
To detect HveC on the cell surface, we used a modification of a published CELISA method (Geraghty et al., 2000) . Monolayers in 96-well plates (4 ϫ 10 4 cells/well) were incubated (2 h at 4°C) with MAbs diluted in PBS containing 3% bovine serum albumin, 0.9 mM CaCl 2 , and 500 mM MgCl 2 (PBS-BSA). After three PBS washes, cells were fixed (30 min RT) with 3% paraformaldehyde (in PBS) and washed as before. Bound MAb was then detected (1 h RT) with horseradish peroxidase-conjugated goat anti-mouse IgG (1/1000 in PBS-BSA). Cells were washed three times with PBS containing 0.1% Tween 20, and then processed as for a standard ELISA.
Optical biosensor analysis
Real-time analysis of gDt binding to porcine HveCt was carried out using a BIACORE X optical biosensor (BIAcore AB) at 25°C essentially as described previously Rux et al., 1998; Willis et al., 1998b; Connolly et al., 2001) . The running buffer was HBS-EP (BIAcore) containing 0.005% Tween 20. Approximately 1750 resonance units (RU) of porcine HveCt were coupled to flow cell 2 (Fc2) of a CM5 sensor chip via primary amines. Flow cell 1 (Fc1) was activated and blocked without the addition of protein. For analysis of gDt binding to HveCt the flow path included both flow cells, the flow rate was 50 l/min, and the data collection rate was 5 Hz. Serial dilutions (in HBS-EP) of PrV and HSV-1gDt were allowed to bind for 2 min and the wash was delayed 2 min to allow for a smooth dissociation curve. The chip surface was regenerated with short pulses of Na 2 CO 3 (pH 9.5-10.5) until the response signal on both flow cells returned to baseline. Sensorgrams were corrected for nonspecific binding by subtracting the signal achieved on Fc1 signal from that of Fc2 signal. The signal obtained when buffer alone was injected was then subtracted from the total signal. Sensorgrams were an-alyzed using BIAEvaluation software (Version 3.0). Calculations assumed that both forms of gDt were dimeric. Model curve fitting was performed using global fitting with a 1:1 Langmuir binding model with drifting baseline. This is the simplest model for the interaction between a receptor and a ligand. It follows the equation A ϩ B ϭ AB. The rate of association (k on ) is measured from the forward reaction and the rate of dissociation (k off ) measured from the reverse reaction. k off /k on ϭ K D . We discounted the effects of mass transport by running samples at different flow rates and ensuring that signals were not flow-rate-dependent.
Transient expression and entry assay
Subconfluent CHO K1 cells in 24-well plates were transfected with 1 g/well plasmid DNA using Fugene (Boehringer Mannheim). Forty-eight hours after transfection, cells were infected with lacZ reporter viruses at input multiplicities of 1 pfu/cell. After 21 h, cells were fixed with methanol/acetone (1:1) and then stained for ␤-galactosidase expression using X-gal (MacGregor et al., 1991) .
Generation of cell lines
CHO K1 cells were transfected with pRM361. Fortyeight hours post-transfection, cells were refed with medium containing 500 g/ml G418. Surviving cells were then cloned twice by limiting dilution. Clones were screened for HveC expression by CELISA using antibody CK6 and for virus entry using HSV-1 hrR3 and PrV BeBlu. A representative clone, termed CHOpHveC, was chosen for further analysis.
Virus blocking assay
Cells were seeded overnight at 4 ϫ 10 4 /well into 96-well plates. Various concentrations of MAbs (in the appropriate growth medium) were added (50 l/well) to chilled monolayers and held at 4°C for 90 min. HSV-1 hrR3 or PrV BeBlu (at input multiplicities of 1-2 pfu/cell; 50-l volume) was added and the plates incubated for 5 (CHO K1) or 7 (PK15) h at 37°C in a humid atmosphere with 5% CO 2 . Cells were then washed once with growth medium, to remove any inoculum-derived ␤-galactosidase, and lysed by the addition of 100 l of the same medium containing 1% NP-40. Fifty microliters of cell lysate was mixed with an equal volume of chlorophenol red-␤-D-galactopyranoside, a chromogenic substrate for ␤-galactosidase. Enzyme activity was monitored by measuring the absorbance at 595 nm over 50 min and was expressed as the change in optical density over time (⌬OD/h). This figure was used as an estimate of the extent of virus entry.
